THIS MONTH HIGHLIGHTS

Docosahexaenoic Acid (DHA) and the Blood Brain Barrier (BBB)

Featuring Dr David L Silver

PhD Professor & Deputy Director

Cardiovascular & Metabolic Disorders Programme

Mfsd2a Discovery & Docosahexaenoic Acid (DHA)

Featuring Dr David L Silver

PhD Professor & Deputy Director

Cardiovascular & Metabolic Disorders Programme

Lysophosphatidylcholine Docosahexaenoic Acid (LPC DHA) vs Triglyceride Docosahexaenoic Acid TG DHA)

Featuring Dr David L Silver

PhD Professor & Deputy Director

Cardiovascular & Metabolic Disorders Programme

Lysophosphatidylcholine Docosahexaenoic Acid (LPC DHA): Link to Cognition, Brain Development and other Organs

Featuring Dr David L Silver

PhD Professor & Deputy Director

Cardiovascular & Metabolic Disorders Programme

Lysophosphatidylcholine Docosahexaenoic Acid (LPC DHA) and Pre-Term Birth

Featuring Dr David L Silver

PhD Professor & Deputy Director

Cardiovascular & Metabolic Disorders Programme

Fundamental Discovery has resulted in Our Revolutionary Platform for Delivering Drugs more Effectively into the Brain.

Learn More


logo

Duke-NUS commercializes discovery for healthy brain development in babies and children

A discovery made at Duke-NUS Medical School (Duke-NUS) has been licensed to a newly launched Singapore-based company, Babynostics Pte Ltd.


Previous highlights